Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Melco Resorts & Entertainment ADR | MLCO | Nov 18, 2024 | 6.00 | -1.96 |
MercadoLibre | MELI | Nov 18, 2024 | 1 916.12 | +1.92 |
Mercantile Bank | MBWM | Nov 18, 2024 | 48.52 | -1.18 |
Mercer International | MERC | Nov 18, 2024 | 6.27 | +1.13 |
Merchants Bancorp | MBIN | Nov 18, 2024 | 39.51 | -1.69 |
Merchants Bancorp B | MBINO | Nov 18, 2024 | 25.38 | +0.07 |
Merchants Bancorp C Pref | MBINN | Nov 18, 2024 | 21.75 | -4.14 |
Merchants Bancorp Pref D | MBINM | Nov 18, 2024 | 25.83 | -2.23 |
Merck & Co | MRK | Nov 18, 2024 | 96.56 | +0.26 |
Mercurity Fintech | MFH | Nov 18, 2024 | 3.50 | -7.41 |
Mercury General | MCY | Nov 18, 2024 | 73.84 | +1.15 |
Mercury Systems | MRCY | Nov 18, 2024 | 38.73 | -1.50 |
Mereo BioPharma ADR | MREO | Nov 18, 2024 | 3.33 | -5.67 |
Meridian | MRBK | Nov 18, 2024 | 14.22 | -0.07 |
MeridianLink | MLNK | Nov 18, 2024 | 21.87 | -0.68 |
Merit Medical Systems | MMSI | Nov 18, 2024 | 103.94 | +2.07 |
Meritage Homes | MTH | Nov 18, 2024 | 177.44 | -1.10 |
Merrill Lynch & Co. | IPB | Nov 18, 2024 | 26.20 | 0.00 |
Mersana Therapeutics | MRSN | Nov 18, 2024 | 2.11 | -4.52 |
Merus N.V | MRUS | Nov 18, 2024 | 44.27 | -4.96 |
Mesa Air Group | MESA | Nov 18, 2024 | 0.85 | -0.75 |
Mesa Laboratories | MLAB | Nov 18, 2024 | 103.05 | +0.60 |
Mesa Royalty Trust | MTR | Nov 18, 2024 | 6.20 | -0.80 |
Mesabi Royalty Trust | MSB | Nov 18, 2024 | 25.71 | +0.78 |
Mesoblast ADR | MESO | Nov 18, 2024 | 10.64 | +5.93 |
Meta Materials | MMAT | Nov 18, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 18, 2024 | 554.40 | +0.06 |
Metagenomi | MGX | Nov 18, 2024 | 1.75 | -3.85 |
Metal Sky Star Acquisition | MSSA | Nov 18, 2024 | 12.00 | 0.00 |
Metalla Royalty & Streaming | MTA | Nov 18, 2024 | 3.05 | +7.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.